Concepedia

Sanjeev Kumar Mendiratta

SK

Statistics

Publications

14

Citations

1.7K

H-Index

14

Active since

1996

Affiliations

Howard Hughes Medical Institute(Current)

Vanderbilt University

Zydus Lifesciences Limited (India)

Opexa Therapeutics (United States)

Woodlands Hospital

Sanjeev Kumar Mendiratta is an author at Howard Hughes Medical Institute specializing in immunology, life sciences, and tumor immunology.

Publications per year

1996–2021

14

Publications

14

CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4

Sanjeev Kumar Mendiratta, William Martin, Seokmann Hong et al. · Immunity · 1997 · 594 citations · Full text

Life Sciences, Genetics, Immunology +16

H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection

William Martin, Geoffrey G. Hicks, Sanjeev Kumar Mendiratta et al. · Cell · 1996 · 324 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.

Toshihiko Kawamura, Kazuyoshi Takeda, Sanjeev Kumar Mendiratta et al. · PubMed · 1998 · 173 citations

Life Sciences, Cancer Biology, Immunology +17

Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo

Toshihiko Kawamura, Kazuyoshi Takeda, Sanjeev Kumar Mendiratta et al. · The Journal of Immunology · 1998 · 141 citations · Full text

Life Sciences, Cancer Biology, Immunology +17

Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.

Sanjeev Kumar Mendiratta, Gerald Thai, Nima K. Eslahi et al. · PubMed · 2001 · 69 citations

Medicine, Immunology, Oncology +17

1–5 of 14